Document:

Third Amended and Restated Voting Agreement

 Exhibit 4.10 
 THIRD AMENDED AND RESTATED VOTING AGREEMENT 
 THIS THIRD AMENDED AND RESTATED
VOTING AGREEMENT (the “Agreement”) is entered into effective as of September 30, 2002, by and among Newgistics, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A Preferred Stock (the
“Series A Preferred Stock”), the Series B Preferred Stock (the “Series B Preferred Stock”), the Series B-l Preferred Stock (the “Series B-l Preferred Stock”), the Series C Preferred Stock (the “Series C Preferred
Stock”) and the Series D Preferred Stock (the “Series D Preferred Stock,” and together with the Series A Preferred Stock, the Series B Preferred Stock, the Series B-l Preferred Stock and the Series C Preferred Stock, the
“Preferred Stock”) listed on the Schedule of Investors attached as Schedule A hereto (each, an “Investor” and collectively, the “Investors”), and certain persons listed on Schedule B hereto as Common Stockholders
(collectively, the “Common Stockholders”) who hold shares of the Company’s common stock, par value $0,001 per share (the “Common Stock”). The Common Stockholders and the Investors are sometimes referred to herein
individually as a “Stockholder” and collectively as the “Stockholders.” Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Series D Preferred Stock Purchase Agreement dated as
of even date herewith by and among the Company and the Investors (the “Purchase Agreement”). 
 RECITALS: 

WHEREAS, the Company and certain of the Stockholders are parties to that certain Voting Agreement dated April 25, 2002 (the
“Prior Agreement”); 
 WHEREAS, the Company and certain of the Investors (the “Series D Investors”) are
parties to the Purchase Agreement pursuant to which the Company has agreed to sell, and such Investors have agreed to purchase, shares of the Series D Preferred Stock of the Company; 

WHEREAS, the Company’s and the Series D Investors’ respective obligations under the Purchase Agreement are conditioned upon the
execution and delivery of this Agreement; and 
 WHEREAS, to induce the Series D Investors to enter into the Purchase Agreement
and purchase shares of Series D Preferred Stock thereunder, the Company, the Investors and the Common Stockholders desire to amend and restate the Prior Agreement on the terms and conditions set forth herein; and 

WHEREAS, the Prior Agreement provides that the terms thereof may be altered, amended, or modified at any time only upon approval of such
alteration, amendment or modification by written consent of the holders of a majority of the shares of Common Stock held by the Common Stockholders and the holders of a majority of the shares of Preferred Stock. 

AGREEMENT: 

NOW, THEREFORE, in consideration of the foregoing premises and certain other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties agree as follows: 
  

	 	1.	Definitions. For purposes of this Agreement, the following definitions shall apply: 

  
 1 

 (a) “Stock” shall mean any and all shares of the capital stock of the Company
which a Stockholder currently holds or may hereafter acquire, including any and all shares of Common Stock, any and all Preferred Shares (as defined in Section Kb) below), and any and all other shares of the capital stock of the Company issued as a
distribution with respect to or in replacement of any of the foregoing. 
 (b) “Preferred Shares” shall mean the
shares of Series A Preferred Stock, Series B Preferred Stock, Series B-l Preferred Stock, Series C Preferred Stock and Series D Preferred Stock and any hereafter acquired shares of the Company’s Preferred Stock, regardless of series, and any
shares of Stock issued upon conversion of or in exchange for any such series of Preferred Stock. 
 2. Size and Composition of
Board of Directors. The Stockholders agree that in any and all elections of directors of the Company during the term of this Agreement, they shall vote all Stock owned or controlled by them, including all Stock which they are entitled to vote under
any voting trust, voting agreement or proxy, to elect a Board of Directors initially comprising seven directors, designated as follows: 
 (a) two directors (the “Common Directors”) designated by the holders of a majority of the shares of the Common Stock held by the Common Stockholders, one of whom shall at all times be the then
current Chief Executive Officer of the Company, such Common Directors initially being Philip Siegel and Clarence Gabriel; 
 (b)
two directors (the “Austin Ventures Directors”) designated by Austin Ventures VII, L.P. (“Austin Ventures”), one of such directors initially being Ken DeAngelis and the other director to be designated by Austin Ventures at a
future date; 
 (c) two directors (the “Series B Directors”), one of whom shall be designated by Spiegel-Hermes
General Service LLC (“Spiegel) for so long as Spiegel holds at least 3,000,000 shares of Stock (as adjusted for any stock splits, stock dividends, recapitalizations, combinations or similar transactions) (the “Spiegel Director”), such
director initially being Rich Lauer, and one of whom shall be designated by R. R. Donnelley & Sons Company (“Donnelley”) for so long as Donnelley holds at least 3,000,000 shares of Stock (as adjusted for any stock splits, stock
dividends, recapitalizations, combinations or similar transactions) (the “Donnelley Director”), such director initially being John Campanelli; and. 
 (d) one director (the “StarVest Director”) designated by StarVest Partners, L.P. {“StarVest”), or by a subsequent investor (the “Subsequent Investor Director”) in the event
that a Subsequent Investment (as defined below) occurs, such director initially being Laura B. Sachar. 
 3. Vacancies; Removal.
In the event of any vacancy in the Board of Directors, the Stockholders agree to vote all outstanding shares of Stock owned or controlled by them and to otherwise use their best efforts to fill such vacancy so that the Board of Directors of the
Company will be comprised of directors designated as provided in Section 2. The Stockholders agree to vote all outstanding shares of Stock owned or controlled by them for the removal of a director whenever (but only whenever) there shall be
presented to the Board of Directors the written direction that such director be removed, signed by (i) Austin Ventures, in the case of an 

  
 2 

 
Austin Ventures Director, (ii) the holders of a majority of the Common Stock held by Common Stockholders, in the case of a Common Director, (iii) Spiegel, in the case of the Spiegel
Director, (iv) Donnelley, in the case of the Donnelley Director, (v) StarVest, in the case of the StarVest director, or (vi) the subsequent investor, in the case of the Subsequent Investor Director. Notwithstanding anything to the
contrary herein, upon receipt by StarVest from the Company of a letter of intent by a new investor to invest in a financing of the Company (i) that raises at least $12,000,000 in exchange for at least 12% of the Company’s equity on a fully
diluted basis and (ii) where such investor requests and receives the right to designate a member of Board of Directors (such transaction being a “Subsequent Investment”), immediately prior to, but in any event contingent upon, the
consummation of such Subsequent Investment, StarVest will relinquish its right to designate a member of the Board of Directors and will present the Board of Directors with written notice to remove the StarVest Director. Immediately prior to, but in
any event contingent upon, the consummation of the Subsequent Investment in which the subsequent investor receives the right to designate a member of the Board of Directors, the StarVest Director will cease to be a member of the Board of Directors.

 4. Indemnity Agreements. As of the date that a director is first elected or appointed to the Board of Directors, the Company
shall enter into an indemnity agreement with each such director in substantially the form attached as Annex A. 
 5. Meetings;
Quorum. The Company agrees to schedule regular meetings of the Board of Directors on a bi-monthly basis unless otherwise determined by the Board of Directors. The Company will give the Common Directors, the Austin Ventures Directors, the Series B
Directors and the StarVest Director written notice at least three days (24 hours, in the case of a telephone meeting) in advance of all meetings of the Board of Directors and all meetings of committees of the Board of Directors. If the Austin
Ventures Director or the StarVest Director is not able to attend a Board of Directors meeting or a meeting of a committee on which he serves, Austin Ventures or StarVest, as applicable, may designate any one person to attend as an observer. In the
event that StarVest relinquishes its rights to designate a director in connection with the Subsequent Investment (as described below), StarVest will retain the right to designate any one person to attend all meetings of the Board of Directors as an
observer. The Company shall furnish Austin Ventures or StarVest, as applicable, with a copy of the minutes and other records of all meetings and other actions taken by the Board of Directors and its committees and all written material given to
directors in connection with such meeting at the same time such materials and information are given to the directors. The Company reserves the right to exclude any observer from all or a portion of a meeting of the Board of Directors, or any
committee thereof, if (a) the Company believes that such exclusion is reasonably necessary to preserve the attorney-client privilege or (b) in the judgment of the Board of Directors, such access would materially impair the due
consideration by the Board of Directors of any matter. 
 6. Expenses. The Company shall reimburse all persons serving as
directors for their actual and reasonable out-of-pocket expenses incurred in attending meetings of the Board of Directors and all committees thereof and otherwise incurred in fulfilling their duties as directors. If an Austin Ventures Director or
the StarVest Director is not able to attend a Board of Directors meeting or a meeting of a committee on which he serves, or in the event that StarVest relinquishes its rights to designate a director in connection with the Subsequent Investment, the
Company shall reimburse one person designated by Austin Ventures or StarVest, as applicable, 

  
 3 

 
for actual and reasonable out-of-pocket expenses incurred in attending such meeting as an observer. 
 7. Legend. During the term of this Agreement, each certificate representing shares of capital stock held by parties hereto will bear a legend in substantially the following form: 

“THE SHARES REPRESENTED HEREBY AND THE VOTING THEREOF ARE SUBJECT TO CERTAIN RESTRICTIONS AND AGREEMENTS CONTAINED IN A VOTING
AGREEMENT AMONG THE HOLDER (OR THE PREDECESSOR IN INTEREST TO THE SHARES), THE COMPANY AND CERTAIN OTHER STOCKHOLDERS OF THE COMPANY. THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF THE VOTING AGREEMENT TO THE HOLDER HEREOF WITHOUT
CHARGE.” 
 The Company shall make a notation on its record and give instructions to any transfer agent of such capital
stock in order to implement the restrictions and agreements contained in this Agreement. 
 8. Termination. This Agreement shall
terminate upon (x) a Qualified Public Offering (as defined in the Company’s Fourth Amended and Restated Certificate of Incorporation, as the same may be amended and restated from time to time), (y) the written agreement signed by
(i) the holders of at least a majority of Common Stock then held by the Common Stockholders and (ii) the holders of at least two-thirds of the Stock (on an as converted to Common Stock basis) held by the Investors, including each holder
that has a right to designate an Austin Ventures Director, a Spiegel Director, a Donnelley Director, or a StarVest Director pursuant to Sections 2(b), (c) and (d) or (z) immediately prior to, but in any event contingent upon, the
consummation of any merger into or consolidation by the Company with any other corporation, partnership or other company (other than a wholly-owned subsidiary corporation) (a “Corporate Transaction”), unless the Company’s stockholders
of record as constituted immediately prior to such Corporate Transaction will, immediately after such Corporate Transaction, hold at least 50% of the voting power of the surviving or acquiring entity. 

9. Miscellaneous. 
 (a) Equitable Relief. The parties recognize that the enforcement of this Agreement is necessary to ensure continuity in the management of the Company, and that the ascertainment of damages in the event of
its breach would be difficult. The parties therefore agree that, in addition to any other available remedies, the parties shall be entitled to injunctive relief in the event of a breach hereof. 

(b) Binding Effect. In addition to any restriction or transfer that may be imposed by any other agreement by which any party hereto may
be bound, this Agreement shall be binding upon the Stockholders and their respective heirs, successors and assigns; provided that for any such transfer to be deemed effective, the transferee shall have executed and delivered an Adoption Agreement
substantially in the form attached hereto as Annex B. Upon the execution and delivery of an Adoption Agreement by any transferee reasonably acceptable to the Company, such transferee shall be deemed to be a party hereto as if such transferee’s
signature appeared on the signature pages hereto. By their execution hereof or any Adoption Agreement, 

  
 4 

 
each of the parties hereto appoints the Company as its attorney-in-fact for the purpose of executing any Adoption Agreement which may be required to be delivered hereunder. 

(c) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard
to conflicts of laws principles. 
 (d) Severability. In the event one or more provisions of this Agreement should, for any
reason be held to be invalid, illegal or unenforceable, such provision shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its
terms. 
 (e) Entire Agreement. This Agreement (including the Schedules hereto) amends and restates the Prior Agreement and
constitutes the full and entire understanding and agreement between the parties with regard to the subject matter hereof. 
 (f)
Amendment. This Agreement may be altered, amended, or modified at any time only upon approval of such alteration, amendment or modification (each, an “Amendment”) by written consent of (i) the Company, (ii) the holders of a
majority of the shares of Common Stock then held by the Common Stockholders and (ii) the holders of at least a majority of the Preferred Shares, provided that no amendment or modification shall be effective if it would adversely affect the
rights of any Investor or group of Investors in a manner different than the other Investors without the written consent of such Investor or the holders of at least two-thirds of the Stock held by such group, provided, further, that Sections 2 or 3
or this Section 9(f) may not be amended (x) to increase the aggregate number of directors set forth therein (other than in connection with an issuance of equity securities of the Company in which the Major Stockholders (as defined in the
Investors’ Rights Agreement) have the right to purchase a portion of such equity securities pursuant to Section 2.3 of the Investors’ Rights Agreement) or, (y) to grant Austin Ventures or its affiliates the right to designate a
majority of the directors of the Company, including in connection with a transaction described in the parenthetical in clause (x) above, in each case, without the approval of a majority of the members of the Board of Directors (excluding any
director designated by Austin Ventures or its affiliates). Any amendment eliminating the right of an Investor to (A) designate a director pursuant to Section 2 (B) designate a Board observer pursuant to Section 5, or
(C) receive reimbursement for expenses pursuant to Section 6, shall require the written consent of such Investor. The Company shall promptly notify the holders of each class of the Company’s voting stock that an Amendment has been
approved in accordance with the terms of this paragraph. 
 (g) Notices. All notices and other communications hereunder shall be
in writing and shall be deemed given if delivered personally or by commercial delivery service, or mailed by registered or certified mail (return receipt requested) or sent via facsimile (with confirmation of receipt) to the parties at the address
for such party set forth beneath such party’s name on Schedule A hereto (or at such other address for a party as shall be specified by like notice) and, in the case of the Company: 

Newgistics, Inc. 

2700 Via Fortuna, Suite 450 
 Austin, TX 78746 

  
 5 

 
Fax:(512)225-6001 
 Attn: Chief Executive Officer 

with a copy (which shall not constitute notice) to 
 Brobeck, Phleger & Harrison LLP 
 4801 Plaza on the Lake 

Austin, TX 78746 

Fax: (512) 230-4001 
 Attn: Samer M. Zabaneh 
 Notices provided in accordance with this
Section 9(g) shall be deemed delivered upon personal delivery, on three business days after deposit in the mail or upon actual receipt by facsimile if received during the recipient’s normal business hours, or at the beginning of the
recipient’s next business day after receipt if the facsimile is not received during the recipient’s normal business hours. All notices by facsimile shall be confirmed promptly after transmission in writing by certified mail or personal
delivery. Any party may change any address to which notice is to be given to it by giving notice as provided above of such change of address. 
 (h) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which, when taken together, shall constitute one and the same instrument.

 (i) Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and do not constitute
a part of this Agreement. 
 [Signature Pages Follow] 

  
 6 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

			
	COMPANY:
	
	NEWGISTICS, INC.
		
	By:	 	 /s/ Clarence J. Gabriel

		 	Clarence J. Gabriel, Jr.
		 	Chief Executive Officer

 [SIGNATURE PAGE
TO THIRD AMENDED AND RESTATED VOTING AGREEMENT] 

  
 7 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

			
	INVESTORS:
	STARVEST PARTNERS, L.P.
	
	 By: StarVest Associates LLC,
 Its General Partner

		
	By:	 	 /s/ Laura Sachar

		 	 Laura B. Sachar
 Managing
Member

	
	STARVEST MANAGEMENT INC., as nominee for
	
	 StarVest Partners, L.P. Advisory Council
 Co-Investment Plan

		
	By:	 	 /s/ Laura Sachar

		 	 Laura B. Sachar

Co-Chairman

 [SIGNATURE PAGE TO THIRD AMENDED AND RESTATED VOTING AGREEMENT] 

  
 8 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

			
	 INVESTORS:
 AUSTIN
VENTURES VII, L.P.

		
	By:	 	 AV Partners VII, L.P.
 its
General Partner

		
	By:	 	 /s/ Kenneth DeAngelis

		 	 Kenneth P. DeAngelis

General Partner

 [SIGNATURE PAGE TO THIRD AMENDED AND RESTATED VOTING AGREEMENT] 

  
 9 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

			
	 INVESTORS:
 AV LABS
I, L.P.

		
	By:	 	 AVL Partners I, L.P.
 its
General Partner

		
	By:	 	 /s/ Rob Adams

		 	 Rob Adams
 General
Partner

 [SIGNATURE PAGE TO THIRD AMENDED AND RESTATED VOTING AGREEMENT] 

  
 10 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

			
	INVESTORS:
	
	SPIEGEL-HERMES GENERAL SERVICE LLC
		
	By:	 	 /s/ Rich Lauer
 Rich Lauer
 President

[SIGNATURE PAGE TO THIRD AMENDED AND RESTATED VOTING AGREEMENT] 

  
 11 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

			
	INVESTORS:
	
	 R.R. DONNELLEY & SONS COMPANY

		
	 By:
	 	 /s/ John Campanelli
 John C. Campanelli
 President - Logistics

[SIGNATURE PAGE TO THIRD AMENDED AND RESTATED VOTING AGREEMENT] 

  
 12 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

			
	 INVESTORS:

	
	 USF VENTURES INC.

		
	 By:
	 	 /s/ Christopher L. Ellis
 Christopher L. Ellis
 President

[SIGNATURE PAGE TO THIRD AMENDED AND RESTATED VOTING AGREEMENT] 

  
 13 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

	
	 INVESTORS:

	
	 /s/ Philip Siegel

	 Philip Siegel

	
	  
 Deena Byers

	
	  
 Steven M. List

	
	  
 Greg A. Moerbe

	
	  
 Kyle Harvey

	
	  
 Casey Leaman

	
	  
 Vinita Busse

 [SIGNATURE PAGE TO THIRD AMENDED AND RESTATED
VOTING AGREEMENT] 

  
 14 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

			
	 COMMON STOCKHOLDERS:

	
	 /s/ Philip Siegel

	 Philip Siegel

	
	 AV LABS I, L.P.

		
	 By:
	 	 AVL Partners I, L.P.
 Its
General Partner

		
	 By:
	 	  

		 	 Rob Adams
 General
Partner

 [SIGNATURE PAGE TO THIRD AMENDED AND RESTATED VOTING AGREEMENT] 

  
 15 

 IN WITNESS WHEREOF, the parties have executed this Third Amended and Restated Voting
Agreement as of the date first written above. 
  

			
	 COMMON STOCKHOLDERS:

	
	        

	 Philip Siegel

	
	 AV LABS I, L.P.

		
	 By:
	 	 AVL Partners I, L.P.
 Its
General Partner

		
	 By:
	 	   /s/ Rob Adams

		 	 Rob Adams
 General
Partner

 [SIGNATURE PAGE TO THIRD AMENDED AND RESTATED VOTING AGREEMENT] 

  
 16 

 SCHEDULE A 

SCHEDULE OF INVESTORS 
  

									
	 Investor Name and Address
	  	Series A	  	Series B/B-l*	  	Series C	  	Series D
	 StarVest Partners, L.P.
	  		  		  		  	31,948,240
	 StarVest Management Inc., as
	  		  		  		  	200,932
	 nominee c/o StarVest Management, Inc.
	  		  		  		  	
	 750 Lexington Avenue
	  		  		  		  	
	
15th Floor
	  		  		  		  	
	 New York, NY 10022
	  		  		  		  	
	 Fax: (212)863-2520
	  		  		  		  	
	 Attn: Laura B. Sachar
	  		  		  		  	
					
	 Austin Ventures VII, L.P.
	  	6,000,000	  	50,403,225	  	76,923,077	  	
	 300 W. 6th Street, Suite 2200
	  		  		  		  	
	 Austin, TX 78701
	  		  		  		  	
	 Fax: (512)476-3952
	  		  		  		  	
	 Attn: Kenneth P. DeAngelis
	  		  		  		  	
					
	 AV Labs I, L.P.
	  	7,000,000	  	6,720,430	  	22,851,964	  	
	 300 W. 6th Street, Suite 2200
	  		  		  		  	
	 Austin, TX 78701
	  		  		  		  	
	 Fax:(512)476-3952
	  		  		  		  	
	 Attn: Rob Adams
	  		  		  		  	
					
	 R. R. Donnelley & Sons Company
	  	4,000,000	  	13,440,860	  	9,191,992	  	
	 77 West Wacker Drive
	  		  		  		  	
	 Chicago, IL 60601-1696
	  		  		  		  	
	 Fax: (312)326-7156
	  		  		  		  	
	 Attn: Corporate Secretary
	  		  		  		  	
					
	 USF Ventures, Inc.
	  	6,000,000	  		  		  	
	 c/o US Freightways Corporation
	  		  		  		  	
	 8550 W. Bryn Mawr Avenue
	  		  		  		  	
	 Suite 700
	  		  		  		  	
	 Chicago, IL 60631
	  		  		  		  	
	 Attn: Christopher L. Ellis
	  		  		  		  	
					
	 virtualcfo Investments, L.P.
	  	50,000	  		  		  	
	 3409 Executive Center Drive
	  		  		  		  	
	 Suite 104
	  		  		  		  	
	 Austin, TX 78731
	  		  		  		  	
	 Fax: (512)345-5484
	  		  		  		  	
	 Attn: VP Finance &
	  		  		  		  	
	 Administration
	  		  		  		  	

  
 17 

									
	 Investor Name and Address
	  	Series A	  	Series B/B-l*	  	Series C	  	Series D
	 Spiegel-Hermes General Service LLC

3500 Lacey Road
 Downers Grove, IL 60515-5432
 Fax:
(630)769-2810
 Attn: Rich Lauer
	  	40,322,580	  		  		  	
					
	 Philip Siegel

1701 Mistywood Drive

Austin, TX 78746
	  	252,016	  	1,923,077	  		  	
					
	 Deena Byers

80 Red River Street, No. 209

Austin, TX 78701
	  	130,567	  		  		  	
					
	 Steven M. List

8121 Bottlebrush Drive

Austin, TX 78750
	  	26,556	  		  		  	
					
	 Greg A. Moerbe 9404 Graceland

Trail Austin, TX 78717
	  	26,566	  		  		  	
					
	 Kyle Harvey 7310 Foxtree Cove

Austin, TX 78750
	  	6,720	  		  		  	
					
	 Casey Leaman

4017 Trailview Mesa Drive

Austin, TX 78746
	  	44,260	  		  		  	
					
	 Vinita Busse 1204 Glenn Cove

Austin, TX 78746
	  	13,278	  		  		  	
	 TOTALS
	  	23,050,000	  	111,387,058	  	110,890,110	  	32,149,172

  

	*	All shares are Series B-l Preferred Stock except for 40,322,580 shares of Series B Preferred Stock held by Spiegel-Hermes General Service LLC. 

  
 18 

 SCHEDULE B 
 SCHEDULE OF COMMON STOCKHOLDERS 
  

			
	 Common Stockholder Name and Address
	  	Shares of Common Stock Held
	 AV Labs I, L.P.

300 W. 6th Street, Suite 2200
 Austin, TX 78701
 Fax: (512)476-3952

Attn: Rob Adams
	  	16,000,000
		
	 Philip Siegel

1701 Mistywood Drive Austin, TX 78746
	  	6,000,000

  
 19 

 ANNEX A 
 FORM OF INDEMNITY AGREEMENT 

  
 20 

 INDEMNITY AGREEMENT 
 THIS INDEMNITY AGREEMENT (this “Agreement”) is made and entered into this day of , 2002, between Newgistics, Inc., a Delaware corporation (the “Company”), and {“Indemnitee”).

 RECITALS: 
 A. Indemnitee, as a member of the Company’s Board of Directors and/or an officer of the Company, performs valuable services for the Company. 

B. The Company and Indemnitee recognize the continued difficulty in obtaining liability insurance for corporate directors, officers,
employees, controlling persons, agents and fiduciaries, the significant increases in the cost of such insurance and the general reductions in the coverage of such insurance. 
 C. The Company and Indemnitee further recognize the substantial increase in corporate litigation in general, subjecting directors, officers, employees, controlling persons, agents and fiduciaries to
expensive litigation risks at the same time as the availability and coverage of liability insurance has been severely limited. 

D. The stockholders of the Company have adopted Bylaws (the “Bylaws”) providing for the indemnification of the officers,
directors, agents and employees of the Company to the maximum extent authorized by Section 145 of the Delaware General Corporation Law, as amended (“DGCL”). 
 E. Indemnitee does not regard the current protection available for the Company’s directors, officers, employees, controlling persons, agents and fiduciaries as adequate under the present
circumstances, and Indemnitee and other directors, officers, employees, controlling persons, agents and fiduciaries of the Company may not be willing to serve or continue to serve in such capacities without additional protection. 

F. The Bylaws and the DGCL, by their non-exclusive nature, permit contracts between the Company and its directors, officers, employees,
controlling persons, agents or fiduciaries with respect to indemnification of such directors. 
 G. The Company (a) desires
to attract and retain the involvement of highly qualified individuals, such as Indemnitee, to serve the Company and, in part, in order to induce Indemnitee to be involved with the Company and (b) wishes to provide for the indemnification and
advancing of expenses to Indemnitee to the maximum extent permitted by law. 
 H. In view of the considerations set forth above,
the Company desires that Indemnitee be indemnified by the Company as set forth herein. 

  
 21 

 AGREEMENT: 
 Now, THEREFORE, in consideration of Indemnitee’s service to the Company, the parties hereto agree as follows: 
 1. Indemnity of Indemnitee. The Company hereby agrees to indemnify Indemnitee to the fullest extent permitted by law, even if such indemnification is not specifically authorized by the other provisions of
this Agreement, the Company’s Certificate of Incorporation (the “Certificate”), the Company’s Bylaws or by statute. In the event of any change after the date of this Agreement in any applicable law, statute or rule which expands
the right of a Delaware corporation to indemnify a member of its Board of Directors or an officer, employee, controlling person, agent or fiduciary, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater
benefits afforded by such change. In the event of any change in any applicable law, statute or rule which narrows the right of a Delaware corporation to indemnify a member of its Board of Directors or an officer, employee, agent or fiduciary, such
change, to the extent not otherwise required by such law, statute or rule to be applied to this Agreement, shall have no effect on this Agreement or the parties’ rights and obligations hereunder except as set forth in Section 9(a) hereof.

 2. Additional Indemnity. The Company hereby agrees to hold harmless and indemnify the Indemnitee: 

(a) Against any and all expenses incurred by Indemnitee, as set forth in Section 3(a) below; and 

(b) Otherwise to the fullest extent not prohibited by the Certificate, the Bylaws or the DGCL. 

 

	 	3.	Indemnification Rights. 

 (a)
Indemnification of Expenses. The Company shall indemnify and hold harmless Indemnitee, together with Indemnitee’s partners, affiliates, employees, agents and spouse and each person who controls any of them or who may be liable within the
meaning of Section 15 of the Securities Act of 1933, as amended (the “Securities Act”), or Section 20 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to the fullest extent permitted by law if
Indemnitee was or is or becomes a party to or witness or other participant in, or is threatened to be made a party to or witness or other participant in, any threatened, pending or completed action, suit, proceeding or alternative dispute resolution
mechanism, or any hearing, inquiry or investigation that Indemnitee and the Company believe might lead to the institution of any such action, suit, proceeding or alternative dispute resolution mechanism, whether civil, criminal, administrative,
investigative or other (hereinafter a “Claim”) against (i) any and all expenses (including attorneys’ fees) and all other costs, expenses and obligations incurred in connection with investigating, defending, being a witness in or
participating in (including on appeal), or preparing to defend, be a witness in or participate in, a Claim, (ii) judgments, fines, penalties and amounts paid in settlement (if such settlement is approved in advance by the Company, which
approval shall not be unreasonably withheld) of a Claim and (iii) any federal, state, local or 

  
 22 

 
foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement (collectively, hereinafter “Expenses”), including all interest,
assessments and other charges paid or payable in connection with or in respect of such Expenses, incurred by Indemnitee by reason of (or arising in part out of) any event or occurrence related to the fact that Indemnitee is or was a director,
officer, employee, controlling person, agent or fiduciary of the Company or any subsidiary of the Company, or is or was serving at the request of the Company as a director, officer, employee, controlling person, agent or fiduciary of another
corporation, partnership, joint venture, trust or other enterprise, or by reason of any action or inaction on the part of Indemnitee while serving in such capacity including, without limitation, any and all losses, claims, damages, expenses and
liabilities, joint or several (including any investigation, legal and other expenses incurred in connection with, and any amount paid in settlement of, any action, suit, proceeding or any claim asserted) under the Securities Act, the Exchange Act or
other federal or state statutory law or regulation, at common law or otherwise, which relate directly or indirectly to the registration, purchase, sale or ownership of any securities of the Company or to any fiduciary obligation owed with respect
thereto (hereinafter an “Indemnification Event”). The Company shall make such payment of Expenses as soon as practicable but in any event no later than 25 days after written demand by Indemnitee therefor is presented to the Company.

 (b) Reviewing Party. Notwithstanding the foregoing, (i) the obligations of the Company under Section 2 shall be
subject to the condition that the Reviewing Party (as described in Section 11(e) hereof) shall not have determined (in a written opinion, in any case in which the Independent Legal Counsel as defined in Section 11(d) hereof is involved)
that Indemnitee would not be permitted to be indemnified under applicable law and (ii) and Indemnitee acknowledges and agrees that the obligation of the Company to make an advance payment of Expenses to Indemnitee pursuant to Section 4(a)
(an “Expense Advance”) shall be subject to the condition that, if, when and to the extent that the Reviewing Party determines that Indemnitee would not be permitted to be so indemnified under applicable law, the Company shall be entitled
to be reimbursed by Indemnitee (who hereby agrees to reimburse the Company) for all such amounts theretofore paid; provided, however, that if Indemnitee has commenced or thereafter commences legal proceedings in a court of competent jurisdiction to
secure a determination that Indemnitee should be indemnified under applicable law, any determination made by the Reviewing Party that Indemnitee would not be permitted to be indemnified under applicable law shall not be binding and Indemnitee shall
not be required to reimburse the Company for any Expense Advance until a final judicial determination is made with respect thereto (as to which all rights of appeal therefrom have been exhausted or lapsed). Indemnitee’s obligation to reimburse
the Company for any Expense Advance shall be unsecured and no interest shall be charged thereon. If there has not been a Change in Control (as defined in Section 11(c) hereof), the Reviewing Party shall be selected by the Board of Directors,
and if there has been such a Change in Control (other than a Change in Control which has been approved by a majority of the Company’s Board of Directors who were directors immediately prior to such Change in Control), the Reviewing Party shall
be the Independent Legal Counsel referred to in Section 3(e) hereof. If there has been no determination by the Reviewing Party or if the Reviewing Party determines that Indemnitee substantively would not be permitted to be indemnified in whole
or in part under applicable law, Indemnitee shall have the right to commence litigation seeking an initial determination by the court or challenging any such determination by the Reviewing Party or any aspect thereof, including the legal or factual
bases therefor, and the Company hereby 

  
 23 

 
consents to service of process and to appear in any such proceeding. Any determination by the Reviewing Party otherwise shall be conclusive and binding on the Company and Indemnitee. 

(c) Contribution. If the indemnification provided for in Section 3(a) above for any reason is held by a court of competent
jurisdiction to be unavailable to an Indemnitee in respect of any losses, claims, damages, expenses or liabilities referred to therein, then the Company, in lieu of indemnifying Indemnitee thereunder, shall contribute to the amount paid or payable
by Indemnitee as a result of such losses, claims, damages, expenses or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company and Indemnitee or (ii) if the allocation provided by
clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company and Indemnitee in connection
with the action or inaction which resulted in such losses, claims, damages, expenses or liabilities, as well as any other relevant equitable considerations. In connection with the registration of the Company’s securities, the relative benefits
received by the Company and Indemnitee shall be deemed to be in the same respective proportions that the net proceeds from the offering (before deducting expenses) received by the Company and the Indemnitee, in each case as set forth in the table on
the cover page of the applicable prospectus, bear to the aggregate public offering price of the securities so offered. The relative fault of the Company and Indemnitee shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or Indemnitee and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. 
 The Company and Indemnitee agree that it would not be just and
equitable if contribution pursuant to this Section 3(c) were determined by pro rata or per capita allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately
preceding paragraph. In connection with the registration of the Company’s securities, in no event shall an Indemnitee be required to contribute any amount under this Section 3(c) in excess of the lesser of (i) that proportion of the
total of such losses, claims, damages or liabilities indemnified against equal to the proportion of the total securities sold under such registration statement which is being sold by Indemnitee or (ii) the proceeds received by Indemnitee from
its sale of securities under such registration statement. No person found guilty of fraudulent misrepresentation (within the meaning of Section 10(f) of the Securities Act) shall be entitled to contribution from any person who was not found
guilty of such fraudulent misrepresentation. 
 (d) Survival Regardless of Investigation. The indemnification and contribution
provided for herein will remain in full force and effect regardless of any investigation made by or on behalf of Indemnitee or any officer, director, employee, agent or controlling person of Indemnitee. 

(e) Change in Control. After the date hereof, the Company agrees that if there is a Change in Control of the Company (other than a Change
in Control which has been approved by a majority of the Company’s Board of Directors who were directors immediately prior to such Change in Control) then, with respect to all matters thereafter arising concerning the rights of Indemnitee to
payments of Expenses under this Agreement or any other agreement or under the 

  
 24 

 
Company’s Certificate or Bylaws as now or hereafter in effect, Independent Legal Counsel (as defined in Section 11(d) hereof) shall be selected by Indemnitee and approved by the Company
(which approval shall not be unreasonably withheld). Such counsel, among other things, shall render its written opinion to the Company and Indemnitee as to whether and to what extent Indemnitee would be permitted to be indemnified under applicable
law. The Company agrees to abide by such opinion and to pay the reasonable fees of the Independent Legal Counsel referred to above and to fully indemnify such counsel against any and all reasonable expenses (including attorneys’ fees), claims,
liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. 
 (f) Mandatory Payment
of Expenses. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee has been successful on the merits or otherwise, including, without limitation, the dismissal of an action without prejudice, in the defense of any
action, suit, proceeding, inquiry or investigation referred to in Section 3(a) hereof or in the defense of any claim, issue or matter therein, Indemnitee shall be indemnified against all Expenses incurred by Indemnitee in connection herewith.

  

	 	4.	Expenses; Indemnification Procedure. 

 (a) Advancement of Expenses. The Company shall advance all Expenses incurred by Indemnitee. The advances to be made hereunder shall be paid by the Company to Indemnitee as soon as practicable but in any
event no later than ten business days after written demand by Indemnitee therefor to the Company. 
 (b) Notice/Cooperation by
Indemnitee. Indemnitee shall give the Company notice in writing in accordance with Section 15 of this Agreement as soon as practicable of any Claim made against Indemnitee for which indemnification will or could be sought under this Agreement.

 (c) No Presumptions; Burden of Proof. For purposes of this Agreement, the termination of any Claim by judgment, order,
settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere, or its equivalent, shall not create a presumption that Indemnitee did not meet any particular standard of conduct or have any particular belief or
that a court has determined that indemnification is not permitted by applicable law. In addition, neither the failure of the Reviewing Party to have made a determination as to whether Indemnitee has met any particular standard of conduct or had any
particular belief, nor an actual determination by the Reviewing Party that Indemnitee has not met such standard of conduct or did not have such belief, prior to the commencement of legal proceedings by Indemnitee to secure a judicial determination
that Indemnitee should be indemnified under applicable law, shall be a defense to Indemnitee’s claim or create a presumption that Indemnitee has not met any particular standard of conduct or did not have any particular belief. In connection
with any determination by the Reviewing Party or otherwise as to whether Indemnitee is entitled to be indemnified hereunder, the burden of proof shall be on the Company to establish that Indemnitee is not so entitled. 

(d) Notice to Insurers. If, at the time of the receipt by the Company of a notice of a Claim pursuant to Section 4(b) hereof, the
Company has liability insurance in effect which may 

  
 25 

 
cover such Claim, the Company shall give prompt notice of the commencement of such Claim to the insurers in accordance with the procedures set forth in each of the Company’s policies. The
Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such action, suit, proceeding, inquiry or investigation in accordance with the terms of such
policies. 
 (e) Selection of Counsel. In the event the Company shall be obligated hereunder to pay the Expenses of any Claim,
the Company shall be entitled to assume the defense of such Claim, with counsel approved by the Indemnitee (which approval shall not be unreasonably withheld) upon the delivery to Indemnitee of written notice of its election to do so. After delivery
of such notice, approval of such counsel by Indemnitee and the retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently incurred by Indemnitee with respect to
the same Claim; provided that (i) Indemnitee shall have the right to employ Indemnitee’s counsel in any such Claim at Indemnitee’s expense and (ii) if (A) the employment of counsel by Indemnitee has been previously
authorized by the Company, (B) Indemnitee shall have reasonably concluded that there is a conflict of interest between the Company and Indemnitee in the conduct of any such defense or (C) the Company shall not continue to retain such
counsel to defend such Claim, then the fees and expenses of Indemnitee’s counsel shall be at the expense of the Company. 

5. Nonexclusivity. The indemnification provided by this Agreement shall be in addition to any rights to which Indemnitee may be entitled
under the Company’s Certificate of Incorporation, its Bylaws, any agreement, any vote of stockholders or disinterested directors, the DGCL, or otherwise. The indemnification provided under this Agreement shall continue as to Indemnitee for any
action Indemnitee took or did not take while serving in an indemnified capacity even though Indemnitee may have ceased to serve in such capacity. 
 6. No Duplication of Payments. The Company shall not be liable under this Agreement to make any payment in connection with any Claim made against any Indemnitee to the extent Indemnitee has otherwise
actually received payment (under any insurance policy, Certificate of Incorporation, Bylaw or otherwise) of the amounts otherwise indemnifiable hereunder. 
 7. Partial Indemnification. If any Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for any portion of Expenses incurred in connection with any Claim, but
not, however, for all of the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion of such Expenses to which Indemnitee is entitled. 
 8. Mutual Acknowledgement. The Company and Indemnitee acknowledge that in certain instances, Federal law or applicable public policy may prohibit the Company from indemnifying its directors, officers,
employees, controlling persons, agents or fiduciaries under this Agreement or otherwise. Each Indemnitee understands and acknowledges that the Company has undertaken or may be required in the future to undertake with the Securities and Exchange
Commission to submit the question of indemnification to a court in certain circumstances for a determination of the Company’s rights under public policy to indemnify Indemnitee. 

  
 26 

 9. Exceptions. Any other provision herein to the contrary notwithstanding, the Company shall
not be obligated pursuant to the terms of this Agreement: 
 (a) Claims Initiated by Indemnitee. To indemnify or advance
expenses to any Indemnitee with respect to Claims initiated or brought voluntarily by Indemnitee and not by way of defense, except (i) with respect to actions or proceedings to establish or enforce a right to indemnify under this Agreement or
any other agreement or insurance policy or under the Company’s Certificate of Incorporation or Bylaws now or hereafter in effect relating to Claims for Indemnifiable Events, (ii) in specific cases if the Board of Directors has approved the
initiation or bringing of such Claim or (iii) as otherwise required under Section 145 of the DGCL, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advance expense payment or insurance
recovery, as the case may be; 
 (b) Claims Under Section 16(b). To indemnify Indemnitee for expenses and the payment of
profits arising from the purchase and sale by Indemnitee of securities in violation of Section 16(b) of the Exchange Act or any similar successor statute; or 
 (c) Claims Excluded Under Section 145 of the Delaware General Corporation Law. To indemnify Indemnitee if (i) Indemnitee did not act in good faith or in a manner reasonably believed by such
Indemnitee to be in or not opposed to the best interests of the Company, (ii) with respect to any criminal action or proceeding, Indemnitee had reasonable cause to believe Indemnitee’s conduct was unlawful or (iii) Indemnitee shall
have been adjudged to be liable to the Company unless and only to the extent the court in which such action was brought shall permit indemnification as provided in Section 145(b) of the DGCL. 

10. Period of Limitations. No legal action shall be brought and no cause of action shall be asserted by or in the right of the Company
against any Indemnitee, any Indemnitee’s estate, spouse, heirs, executors or personal or legal representatives after the expiration of five years from the date of accrual of such cause of action, and any claim or cause of action of the Company
shall be extinguished and deemed released unless asserted by the timely filing of a legal action within such five-year period; provided, however, that if any shorter period of limitations is otherwise applicable to any such cause of action, such
shorter period shall govern. 
  

	 	11.	Construction of Certain Phrases. 

(a) For purposes of this Agreement, references to the “Company” shall include, in addition to the resulting corporation, any
constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees, agents or
fiduciaries, so that if Indemnitee is or was a director, officer, employee, agent, control person or fiduciary of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee,
control person, agent or fiduciary of another corporation, partnership, joint venture, employee benefit plan, trust or other enterprise, Indemnitee shall stand in the same position under the provisions of this Agreement with respect to the resulting
or surviving corporation as Indemnitee would have with respect to such constituent corporation if its separate existence had continued. 

  
 27 

 (b) For purposes of this Agreement, references to “other enterprises” shall
include employee benefit plans; references to “fines” shall include any excise taxes assessed on any Indemnitee with respect to an employee benefit plan; and references to “serving at the request of the Company” shall include any
service as a director, officer, employee, agent or fiduciary of the Company which imposes duties on, or involves services by, such director, officer, employee, agent or fiduciary with respect to an employee benefit plan, its participants or its
beneficiaries; and if any Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the interests of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in a manner
“not opposed to the best interests of the Company” as referred to in this Agreement. 
 (c) For purposes of this
Agreement a “Change in Control” shall be deemed to have occurred if (i) any “person” (as such term is used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act), other than a trustee or other fiduciary holding securities
under an employee benefit plan of the Company or a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, (A) who is or becomes the
beneficial owner, directly or indirectly, of securities of the Company representing 10% or more of the combined voting power of the Company’s then outstanding Voting Securities, increases his or her beneficial ownership of such securities by 5%
or more over the percentage so owned by such person or (B) becomes the “beneficial owner” (as defined in Rule 13d-3 under said Exchange Act), directly or indirectly, of securities of the Company representing more than 20% of the total
voting power represented by the Company’s then outstanding Voting Securities, (ii) during any period of two consecutive years, individuals who at the beginning of such period constitute the Board of Directors of the Company and any new
director whose election by the Board of Directors or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the
period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof or (iii) the stockholders of the Company approve a merger or consolidation of the Company with any other
corporation other than a merger or consolidation which would result in the Voting Securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into Voting Securities
of the surviving entity) at least 80% of the total voting power represented by the Voting Securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, or the stockholders of the Company approve a
plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of (in one transaction or a series of transactions) all or substantially all of the Company’s assets. 

(d) For purposes of this Agreement, “Independent Legal Counsel” shall mean an attorney or firm of attorneys, selected in
accordance with the provisions of Section 3(d) hereof, who shall not have otherwise performed services for the Company or any Indemnitee within the last three years (other than with respect to matters concerning the right of any Indemnitee
under this Agreement, or of other indemnitees under similar indemnity agreements). 
 (e) For purposes of this Agreement, a
“Reviewing Party” shall mean any appropriate person or body consisting of a member or members of the Company’s Board of Directors or any 

  
 28 

 
other person or body appointed by the Board of Directors who is not a party to the particular Claim for which Indemnitee are seeking indemnification, or Independent Legal Counsel. 

(f) For purposes of this Agreement, “Voting Securities” shall mean any securities of the Company that vote generally in the
election of directors. 
 12. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall
constitute an original. 
 13. Binding Effect; Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of and be enforceable by the parties hereto and their respective successors, assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the
Company, spouses, heirs, and personal and legal representatives. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all, or a substantial part, of the
business and/or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to
perform if no such succession had taken place. This Agreement shall continue in effect with respect to Claims relating to Indemnifiable Events regardless of whether any Indemnitee continues to serve as a director, officer, employee, agent,
controlling person or fiduciary of the Company or of any other enterprise, including subsidiaries of the Company, at the Company’s request. 
 14. Attorneys’ Fees. In the event that any action is instituted by an Indemnitee under this Agreement or under any liability insurance policies maintained by the Company to enforce or interpret any
of the terms hereof or thereof, any Indemnitee shall be entitled to be paid all Expenses incurred by Indemnitee with respect to such action if Indemnitee is ultimately successful in such action, and shall be entitled to the advancement of Expenses
with respect to such action, unless, as a part of such action, a court of competent jurisdiction over such action determines that the material assertions made by Indemnitee as a basis for such action were not made in good faith or were frivolous. In
the event of an action instituted by or in the name of the Company under this Agreement to enforce or interpret any of the terms of this Agreement, Indemnitee shall be entitled to be paid all Expenses incurred by Indemnitee in defense of such action
(including costs and expenses incurred with respect to Indemnitee counterclaims and cross-claims made in such action), and shall be entitled to the advancement of Expenses with respect to such action, unless, as a part of such action, a court having
jurisdiction over such action determines that the Indemnitee’s material defenses to such action were made in bad faith or were frivolous. 
 15. Notice. All notices and other communications required or permitted hereunder shall be in writing, shall be effective when given, and shall in any event be deemed to be given (a) five calendar
days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one business day after the business day of deposit with
Federal Express or similar overnight courier, freight prepaid, or (d) one day after the business day of delivery by facsimile transmission, if deliverable by facsimile transmission, with copy by first class mail, postage

  
 29 

 
prepaid, and shall be addressed if to Indemnitee, at Indemnitee’s address as set forth beneath Indemnitee’s signature to this Agreement and if to the Company at the address of its
principal corporate offices (attention: Chief Executive Officer) or at such other address as such party may designate by ten calendar days’ advance written notice to the other party hereto. 

16. Consent to Jurisdiction. The Company and Indemnitee each hereby irrevocably consent to the jurisdiction of the courts of the State of
Delaware for all purposes in connection with any action or proceeding which arises out of or relates to this Agreement and agree that any action instituted under this Agreement shall be commenced, prosecuted and continued only in the Court of
Chancery of the State of Delaware in and for New Castle County, which shall be the exclusive and only proper forum for adjudicating such a claim. 
 17. Severability. The provisions of this Agreement shall be severable in the event that any of the provisions hereof (including any provision within a single section, paragraph or sentence) are held by a
court of competent jurisdiction to be invalid, void or otherwise unenforceable, and the remaining provisions shall remain enforceable to the fullest extent permitted by law. Furthermore, to the fullest extent possible, the provisions of this
Agreement (including, without limitations, each portion of this Agreement containing any provision held to be invalid, void or otherwise unenforceable, that is not itself invalid, void or unenforceable) shall be construed so as to give effect to the
intent manifested by the provision held invalid, illegal or unenforceable. 
 18. Choice of Law. This Agreement shall be
governed by and its provisions construed and enforced in accordance with the laws of the State of Delaware, as applied to contracts between Delaware residents, entered into and to be performed entirely within the State of Delaware, without regard to
the conflict of laws principles thereof. 
 19. Subrogation. In the event of payment under this Agreement, the Company shall be
subrogated to the extent of such payment to all of the rights of recovery of Indemnitee who shall execute all documents required and shall do all acts that may be necessary to secure such rights and to enable the Company effectively to bring suit to
enforce such rights. 
 20. Amendment and Termination. No amendment, modification, termination or cancellation of this Agreement
shall be effective unless it is in writing signed by all parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver
constitute a continuing waiver. 
 21. Integration and Entire Agreement. This Agreement sets forth the entire understanding
between the parties hereto and supersedes and merges all previous written and oral negotiations, commitments, understandings and agreements relating to the subject matter hereof between the parties hereto. 

22. No Construction as Employment Agreement. Nothing contained in this Agreement shall be construed as giving the Indemnitee any right to
be retained in the employ of the Company or any of its subsidiaries. 

  
 30 

 23. Corporate Authority. The Board of Directors of the Company has approved the terms of
this Agreement. 
 [Signature Page Follows] 

  
 31 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the day and
year first above written. 
 [Signature Page to Indemnity Agreement] 

  
 32 

 ANNEX B 
 ADOPTION AGREEMENT 
 This Adoption Agreement (“Adoption Agreement”) is
executed by the undersigned (the “Transferee”) pursuant to the terms of that certain Third Amended and Restated Voting Agreement dated as of September    , 2002 (the “Agreement”) by and among the Company and
certain of its Stockholders. Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Agreement. By the execution of this Adoption Agreement, the Transferee agrees as follows: 

1. Acknowledgement. Transferee acknowledges that Transferee is acquiring certain shares of the capital stock of the Company (the
“Stock”), subject to the terms and conditions of the Agreement. 
 2. Agreement. As partial consideration for such
transfer, Transferee (i) agrees that the Stock acquired by Transferee shall be bound by and subject to the terms of the Agreement, and (ii) hereby adopts the Agreement with the same force and effect as if Transferee were originally a party
thereto. 
 3. Notice. Any notice required or permitted by the Agreement shall be given to Transferee at the address listed
beside Transferee’s signature below. 
 4. Joinder. The spouse of the undersigned Transferee, if applicable, executes this
Adoption to acknowledge its fairness and that it is in such spouse’s best interests and to bind to the terms of the Agreement such spouse’s community interest, if any, in the Stock. 

EXECUTED AND DATED this      day of
            ,         . 
  

			
		  	TRANSFEREE
		
		  	By:
		  	Name:
		  	Title:
		  	Address:
		
		  	Fax:
		
		  	Spouse (if applicable):
		  	Name:
		
	 ACKNOWLEDGED AND ACCEPTED:
	  	
		
	 NEWGISTICS, INC.
	  	
		
	 By:
	  	
	 Name:
	  	
	 Title:
	  	

  
 33Omnibus Amendment No. 1

 Exhibit 4.11 
 NEWGISTICS, INC. 
 OMNIBUS AMENDMENT NO. 1 TO 

THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 
 THIRD AMENDED AND RESTATED CO-SALE AND FIRST REFUSAL AGREEMENT 
 THIRD
AMENDED AND RESTATED VOTING AGREEMENT 
 THIS OMNIBUS AMENDMENT NO. 1 (this “Amendment
Agreement”) is entered into as of April 11, 2003 by and among Newgistics, Inc., a Delaware corporation (the “Company”), certain of the Investors and the Founders set forth on Schedules A and B,
respectively, to Third Amended and Restated Investors’ Rights Agreement (the “Investors’ Rights Agreement”), certain of the Investors and the Founders set forth on Schedules A and B, respectively, to Third
Amended and Restated Co-Sale and First Refusal Agreement (the “Co-Sale Agreement”) and certain of the Stockholders set forth on Schedules A and B to Third Amended and Restated Voting Agreement (the “Voting
Agreement”), each dated as of September 30, 2002. Capitalized terms used herein but not defined herein shall have the respective meanings ascribed to them in the Investors’ Rights Agreement, the Co-Sale Agreement or the Voting
Agreement, as applicable. 
 RECITALS 

WHEREAS, the Company desires to sell Units (as defined in the Purchase Agreement) to certain current stockholders
of the Company (the “Unit Investors”) on the terms and conditions set forth in the Unit Purchase Agreement dated as of the date hereof (the “Purchase Agreement”); 

WHEREAS, the purchase of the Units by the Unit Investors is conditioned upon amendment of the Investors’
Rights Agreement, the Co-Sale Agreement and the Voting Agreement as herein provided; and 
 WHEREAS, the
parties hereto desire to amend the Investors’ Rights Agreement, the Co-Sale Agreement and the Voting Agreement as herein provided to facilitate the sale of Units to the Unit Purchasers. 

AGREEMENT 
 NOW, THEREFORE, pursuant to Section 4.7 of the Investors’ Rights Agreement, Section 4.7 of the Co-Sale Agreement and Section 9(f) of the Voting Agreement,
and in consideration of the foregoing premises, the agreements set forth herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree
as follows: 

 1. Amendments of Investors’ Rights Agreement. 

1.1. Registrable Securities. Section 1.1(f) of the Investors’ Rights Agreement is amended
and restated in its entirety to read as follows: 
 The term “Registrable Securities”
means (i) the Common Stock issuable or issued upon conversion of the Series A Preferred Stock, the Series AA Preferred Stock, the Series B Preferred Stock, the Series B-l Preferred Stock, the Series BB-1 Preferred Stock, the Series C
Preferred Stock, the Series CC Preferred Stock, the Series D Preferred Stock and the Series E Preferred Stock, or upon exercise of the Series E Warrants (as defined below) or any warrant (each a “Common Warrant”) issued
pursuant to the Series B Preferred Stock Purchase Agreement, dated as of July 10, 2001, between the Company and the Investors party thereto, held by any Investor or proper transferee, (ii) the Common Stock issuable upon the exercise of any
warrants that may be issued to R. R. Donnelley & Sons Company as set forth in a Co-Marketing Agreement, as amended from time to time, between the Company and R. R. Donnelley & Sons Company, and (iv) any Common Stock of the
Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of the shares referenced in
(i) above, excluding in all cases, however, any Registrable Securities sold by a Holder in a transaction in which his rights under this Section 1 are not assigned. 

1.2. Series E Warrants. Section 1.1 of the Investors’ Rights Agreement is amended to
incorporate the following as a new Section l.l(i): 
 “Series E Warrants” shall
mean the Warrants to Purchase Shares issued pursuant to the Unit Purchase Agreement dated as of April 11, 2003. 
 1.3. Limited Rights of First Refusal. Section 2.3 of the Investors’ Rights Agreement is amended and restated in its entirety to read as follows: 

If the Company shall issue any equity securities, options therefor or securities convertible or exercisable for equity
securities (each an “Equity Security” and together, “Equity Securities”), each Founder, each holder of at least 500,000 shares of Series D Preferred Stock (each a “Series D Holder”)
and each Major Stockholder shall be entitled to purchase a portion of such Equity Securities to be issued equal to the aggregate number of such Equity Securities multiplied by a fraction, the numerator of which is the number of shares of
Common Stock held by such Founder, Series D Holder or Major Stockholder (assuming full conversion of all outstanding shares of Preferred Stock and full exercise of all Common Warrants and Series E Warrants), and the denominator of which is the
aggregate number of shares of Common Stock of the Company then outstanding (assuming full conversion of all outstanding shares of Preferred Stock and full exercise of all Common Warrants and Series E Warrants); provided, that such limited
rights of first refusal shall not apply to: (a) issuances of Equity Securities 

  
 2

 
pursuant to the conversion of Preferred Stock of the Company; (b) issuances of Equity Securities to officers, directors or employees of, or consultants to, the Company as compensation for
services, directly or pursuant to a stock option plan or a restricted stock purchase plan, in each case as approved by at least two-thirds of all of the members of the Board of Directors, including at least one Austin Ventures Director (as defined
in the Third Amended and Restated Voting Agreement, dated as of the date hereof (the “Voting Agreement”}, among the Company and certain stockholders of the Company) and one Series B Director (as defined in the Voting
Agreement); (c) issuances of Equity Securities to banks, savings and loan associations, equipment lessors or other similar lending institutions in connection with working capital or other credit facilities or equipment financing to the Company;
(d) issuances of Equity Securities as a dividend or distribution on the Preferred Stock or to all stockholders of the Company generally; (e) issuances of Equity Securities in connection with bona fide business or technology acquisitions
(or licenses) of, or by, the Company, whether by merger, consolidation, sale of assets, sale or in each case, as approved by the Board of Directors of the Company including at least one Austin Ventures Director and one Series B Director;
(f) issuances of Equity Securities pursuant to Section 4 of the Co-Marketing Agreement, as amended from time to time, between the Company and R. R. Donnelley & Sons Company, or upon exercise of any warrants that may be issued to
R. R. Donnelley & Sons Company thereunder; (g) issuances of Equity Securities pursuant to the Unit Purchase Agreement, including the issuance of Series E Warrants and Senior Subordinated Promissory Notes (as defined therein) or any
Equity Securities issuable upon exercise or conversion thereof; and provided, further, that the number of equity securities issued pursuant to (f) above may not represent, in the aggregate, in excess of 4,000,000 shares of capital stock
as determined on a fully diluted basis at any time (as adjusted for any stock splits, stock dividends, recapitalizations, combinations or similar transactions), and the number of shares issued pursuant to (c) and (e) above may not
represent, in the aggregate, in excess of 8,500,000 shares of capital stock as determined on a fully diluted basis at any time (as adjusted for any stock splits, stock dividends, recapitalizations, combinations or similar transactions). The price of
Equity Securities which a Founder, Series D Holder or Major Stockholder becomes entitled to purchase under this Section 2.3 shall be the same price at which such Equity Securities are offered to others. A Founder, Series D Holder or
Major Stockholder may exercise its limited rights of first refusal under this Section 2.3 to purchase Equity Securities by paying the purchase price therefor at the principal office of the Company within 30 days after receipt of notice
from the Company stating the number or amount of Equity Securities it intends to issue and the price and characteristics thereof. The Founders, Series D Holders and Major Stockholders shall pay such purchase price in cash or by check; provided,
however, that if the Company is indebted to such Founder, Series D Holder or Major Stockholder, the Founder, Series D Holder or Major Stockholder shall be entitled, at its sole option, to credit against the purchase price all or any portion of
the Company’s indebtedness to such Founder, Series D Holder or Major Stockholder which is then due (declared but unpaid dividends on 

  
 3

 
the Preferred Stock shall not be deemed to be indebtedness for purposes of such credit). A Founder, Series D Holder or Major Stockholder’s limited rights of first refusal hereunder shall be
deemed to be exercised immediately prior to the close of business on the day of payment of the purchase price in accordance with the foregoing provisions, and at such time such Founder, Series D Holder or Major Stockholder shall be treated for all
purposes as the record holder of the Equity Securities purchased upon exercise of such limited rights of first refusal. As promptly as practicable (and in any event within ten days) on or after the purchase date, the Company shall issue and deliver
at its principal office a certificate or certificates for the number of full shares of Common Stock or the number of full shares or amount, whichever is applicable, of Equity Securities together with cash for any fraction of a share or portion of an
Equity Security at the purchase price to which the Founder, Series D Holder or Major Stockholder is entitled hereunder. Each Series D Holder and Major Stockholder shall be entitled to assign its rights to purchase Equity Securities pursuant hereto
to any partner or affiliate of such Series D Holder or Major Stockholder, as applicable, including partners and affiliates that are not stockholders of the Company. 

1.4. 2000 Stock Option/Stock Issuance Plan. Section 2.4 of the Investors’ Rights
Agreement is amended and restated in its entirety to read as follows: 
 The Company shall not issue (or reserve
for issuance) shares of capital stock or rights to acquire capital stock to employees, consultants and directors except for options in respect of 77,585,000 (as adjusted for any stock splits, stock dividends, recapitalizations, combinations, or
similar transactions) shares of Common Stock authorized for issuance under the Company’s 2000 Stock Option/Stock Issuance Plan (including all shares of Common Stock previously issued under such plan), unless such issuance is approved by
(i) the Board of Directors with the Austin Ventures Director (as defined in the Voting Agreement) concurring, and (ii) the Investors holding at least of two-thirds of the Registrable Securities then held by all of the Investors.

 1.5. Sale of Company. Section 3 of the Investors’ Rights Agreement is amended
and restated in its entirety to read as follows: 
 3.1 Sale of the Company. If on any Redemption
Date (as defined in the Company’s Fifth Amended and Restated Certificate of Incorporation) the funds of the Company legally available for redemption of Preferred Stock are insufficient to redeem the total number of shares of Preferred Stock to
be redeemed on such Redemption Date, the holders of a majority of the then outstanding shares of Preferred Stock may elect, by giving written notice to that effect (a “Sale Notice”) to the Company not later than 90 days
following such Redemption Date, to defer any such redemption of shares of Preferred Stock that would otherwise be redeemed on such Redemption Date and to initiate procedures for the Sale of the Company. For purposes hereof, a “Sale of the
Company” means either (i) a sale of all issued and outstanding stock of the Company, (ii) a sale of all of the assets and business of the Company and a liquidation of the Company promptly

  
 4

 
following such sale, or (iii) a merger or consolidation of the Company with or into another entity, in each case for cash or securities. If the Sale Notice is issued, all holders of
Preferred Stock shall be deemed to have so deferred and the following procedure shall apply. 
 3.2 Sale
Procedure. The Board of Directors shall, as promptly as practicable, engage a Qualified Investment Banker (as defined below) at the Company’s expense to represent the Company and the stockholders of the Company in connection with the
Sale of the Company. The Company, the Founders and the Investors shall use their reasonable best efforts to consummate the Sale of the Company as soon as practicable after receipt of the Sale Notice, but shall not be required to solicit offers for
more than six months following the date that the Qualified Investment Banker begins such engagement. Notwithstanding the foregoing sentence, “reasonable best efforts”” shall not be interpreted to require the Founders and
the Investors to take any actions other than voting and selling their shares of capital stock of the Company, except as such Founders and Investors may be required to act on behalf of the Company as an officer or director. For purposes hereof, a
“Qualified Investment Banker” shall be a nationally recognized investment banking firm selected by a majority of the entire Board of Directors. 

3.3 Sale Offers. At such time as the Company suspends its solicitation of offers for the Sale of the
Company, it shall give each Investor written notice (an “Offer Notice”) describing each offer (each, a “Sale Offer”) received by the Company, setting forth the name of the proposed purchaser, a
description of the consideration to be received upon the sale, the date for closing the sale and the other material terms of the Sale Offer. The holders of a majority of the then outstanding shares of Preferred Stock may select one Sale Offer by
giving written notice of such selection to the Company within 30 days following receipt of the Offer Notice. 

3.4 Acceptance; Counter Offer. Notice of the Sale Offer selected by the holders of Preferred Stock pursuant
to Section 3.3 above shall be given by the Company to each Founder. Within 30 days following receipt of notice of such selection, the Company (or, if the selected Sale Offer is an offer to purchase capital stock of the Company, the
Founders) must accept the selected Sale Offer or the Company must make a counter offer (a “Counter Offer”) to purchase all outstanding shares of Preferred Stock on the same terms and conditions set forth in the selected Sale
Offer. The Company shall be deemed to have made a Counter Offer if within such 60 day period the Company or Founders holding the required number or percentage of shares of capital stock specified in the selected Sale Offer fail to accept the
selected Sale Offer or the Board of Directors or stockholders of the Company fail to take any action required to be taken under the Delaware General Corporation Law or other applicable law to consummate the selected Sale Offer. If the selected Sale
Offer is an offer to acquire the assets and business of the Company or for a merger, the Counter Offer shall include an offer to pay each holder of Preferred Stock the aggregate consideration that such holder would receive if there occurred a
liquidation of the Company immediately following the closing of the Sale Offer. 

  
 5

 3.5 Purchase and Sale. If a Sale Offer is made and no Counter
Offer is made, the Company or, if the Sale Offer is to purchase shares of capital stock of the Company, each Founder and Investor, shall sell the assets and business of the Company or shares of capital stock of the Company, as the case may be, on
the terms set forth in the Sale Offer. If a Sale Offer is made and a Counter Offer is made by the Company, each holder of Preferred Stock shall sell, and the Company shall purchase, all of the shares of Preferred Stock. 

3.6 Voting, Etc. Each Founder and Investor agrees to vote all shares of voting stock held by such Founder
and Investor to cause the Company to effect a Sale of the Company pursuant to any Sale Offer accepted by the Company, including, without limitation, voting all shares of voting stock held by such Founder or Investor to approve a sale of assets by
the Company followed by the liquidation and dissolution of the Company or to adopt a plan of merger of consolidation by the Company included in the terms of the Sale Offer, and to sell all shares of capital stock of the Company held by such Founder
or Investor pursuant to such Sale of the Company. 
 3.7 Lapse. If all parties to this Agreement
have performed their obligations under this Section 3 and if the Sale of the Company is not consummated prior to the expiration of 18 months after the date of the Sale Notice through no fault of the Company, the right herein granted to
effect a Sale of the Company and the deferral of redemption rights shall each lapse. Nothing in this Section 3 shall be deemed to prevent the Company from engaging in an initial public offering of its securities during the time a Sale of
the Company is being sought. 
 1.6. Notices. Section 4.5 of the Investors’
Rights Agreement is amended and restated in its entirety to read as follows:. 
 All notices and other
communications hereunder shall be in writing and shall be deemed given if delivered personally or by commercial delivery service, or mailed by registered or certified mail (return receipt requested) or sent via facsimile (with confirmation of
receipt) to the parties at the address for such party set forth beneath such party’s name on Schedule A and Schedule B hereto (or at such other address for a party as shall be specified by like notice) and, in the case of the
Company: 
 Newgistics, Inc. 
 2700 Via Fortuna, Suite 450 (Suite 300 after April 25, 2003) 
 Austin, Texas
78746 
 Fax:(512)225-6001 
 Attn: Chief Executive Officer 

  
 6

 with a copy (which shall not constitute notice) to: 

Andrews & Kurth L.L.P. 
 111 Congress Avenue, Suite 1700 
 Austin, Texas 78701 

Fax: (512)320-9292 
 Attn: Samer M. Zabaneh 
 1.7. Amendments and Waivers.
Section 4.7 of the Investors’ Rights Agreement is amended and restated in its entirety to read as follows: 
 Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with
the written consent of the Company and the holders of a majority of the then outstanding shares of Preferred Stock (or Common Stock issued upon conversion of any of the foregoing); provided that no amendment or modification shall be effective
if it would adversely affect the rights of any Holder or group of Holders in a manner different than the other Holders without the written consent of such Holder or the holders of at least two-thirds of the Registrable Securities held by such group;
and provided further, that the grant of subsequent registration rights which are senior or pari passu to the Founders’ rights shall not require consent of the Founders. Any amendment or waiver effected in accordance with this
Section shall be binding upon each holder of any Registrable Securities or Founder Registrable Securities then outstanding, each future holder of all such Registrable Securities and Founder Registrable Securities, and the Company. 

2. Amendments of Co-Sale Agreement. 

2.1. Notices. Section 4.2 of the Co-Sale Agreement is amended and restated in its entirety as
follows: 
 All notices and other communications hereunder shall be in writing and shall be deemed given if
delivered personally or by commercial delivery service, or mailed by registered or certified mail (return receipt requested) or sent via facsimile (with confirmation of receipt) to the parties at the address for such party set forth beneath such
party’s name on Schedule A hereto (or at such other address for a party as shall be specified by like notice) and, in the case of the Company: 
 Newgistics, Inc. 
 2700 Via Fortuna, Suite 450 (Suite 300 after
April 25, 2003) 
 Austin, TX 78746 

Fax:(512)225-6001 
 Attn: Chief Executive Officer 

  
 7

 with a copy (which shall not constitute notice) to 

Andrews & Kurth L.L.P. 
 111 Congress Avenue, Suite 1700 
 Austin, TX 78701 

Fax:(512)320-9292 
 Attn: Samer M. Zabaneh 
 Notices provided in
accordance with this Section 4.2 shall be deemed delivered upon personal delivery, on three business days after deposit in the mail or upon actual receipt by facsimile if received during the recipient’s normal business hours, or at
the beginning of the recipient’s next business day after receipt if the facsimile is not received during the recipient’s normal business hours. All notices by facsimile shall be confirmed promptly after transmission in writing by certified
mail or personal delivery. Any party may change any address to which notice is to be given to it by giving notice as provided above of such change of address. 
 2.2. Amendments and Waivers. Section 4.7 of the Co-Sale Agreement is amended and restated in its entirety as follows: 

Other than with respect to amendments to Schedule A or Schedule B hereto, any amendment or modification of
this Agreement shall be effective only if evidenced by a written instrument executed by (i) the Company, (ii) the holders of at least a majority of the shares of Stock held by all the Founders hereunder and (iii) the holders of a
majority of the then outstanding shares of Preferred Stock (or Common Stock issued upon conversion of any of the foregoing), other than in respect of Section 4.1(c), which shall require two-thirds of the holders of such Stock,
provided that no amendment or modification shall be effective if it would adversely affect the rights of any Investor or group of Investors in a manner different than the other Investors without the written consent of such Investor or the
holders of at least two-thirds of the Stock held by such group. Any waiver hereunder shall be effective only if evidenced by a written instrument executed by the holders of at least a majority of the shares of Stock held by all the Investors or by
the holders of a majority of the shares of Common Stock held by all the Founders, as the case may be, whose rights are being waived. 
 3. Amendments of Voting Agreement. 
 3.1. Size
and Composition of Board of Directors. Section 2(d) of the Voting Agreement is amended and restated in its entirety as follows: 
 one director (the “StarVest Director”) designated by StarVest Partners, L.P. (“StarVest”), such director initially being Laura B. Sachar. 

  
 8

 3.2. Vacancies; Removal. Section 3 of the Voting
Agreement is amended and restated in its entirety as follows: 
 In the event of any vacancy in the Board of
Directors, the Stockholders agree to vote all outstanding shares of Stock owned or controlled by them and to otherwise use their best efforts to fill such vacancy so that the Board of Directors of the Company will be comprised of directors
designated as provided in Section 2. The Stockholders agree to vote all outstanding shares of Stock owned or controlled by them for the removal of a director whenever (but only whenever) there shall be presented to the Board of Directors
the written direction that such director be removed, signed by (i) Austin Ventures, in the case of an Austin Ventures Director, (ii) the holders of a majority of the Common Stock held by Common Stockholders, in the case of a Common
Director, (iii) Spiegel, in the case of the Spiegel Director, (iv) Donnelley, in the case of the Donnelley Director, or (v) StarVest, in the case of the StarVest director. 

3.3. Notices. Section 9(g) of the Voting Agreement is amended and restated in its entirety as
follows: 
 All notices and other communications hereunder shall be in writing and shall be deemed given if
delivered personally or by commercial delivery service, or mailed by registered or certified mail (return receipt requested) or sent via facsimile (with confirmation of receipt) to the parties at the address for such party set forth beneath such
party’s name on Schedule A hereto (or at such other address for a party as shall be specified by like notice) and, in the case of the Company: 
 Newgistics, Inc. 
 2700 Via Fortuna, Suite 450 (Suite 300 after April 25,
2003) 
 Austin, TX 78746 
 Fax:(512)225-6001 
 Attn: Chief Executive Officer 

with a copy (which shall not constitute notice) to 
 Andrews & Kurth L.L.P. 
 111 Congress Avenue, Suite 1700 

Austin, TX 78701 
 Fax:(512)320-9292 
 Attn: Samer M. Zabaneh 

Notices provided in accordance with this Section 9(g) shall be deemed delivered upon personal delivery, on
three business days after deposit in the mail or upon actual receipt by facsimile if received during the recipient’s normal business hours, or at the beginning of the recipient’s next business day after receipt if the facsimile is not
received during the recipient’s normal business hours. All notices by facsimile shall be confirmed promptly after transmission in writing by certified mail or personal delivery. Any party may change any address to which notice is to be given to
it by giving notice as provided above of such change of address. 

  
 9

 3.4. Drag Along. The Voting Agreement is amended to
incorporate the following as a new Section 10: 
 (a) If, at any time, the Board of Directors and
holders of at least a majority of the outstanding shares of Series E Preferred Stock vote or consent to a Sale of the Company (as defined in the Third Amended and Restated Investors’ Rights Agreement dated as of September 30, 2002, as may
be amended from time to time) (an “Approved Sale”), all Stockholders shall consent to and raise no objections against the Approved Sale, and if the Approved Sale is structured as (A) a merger, share exchange or
consolidation of the Company, or a sale of all or substantially all of the assets of the Company or any other form of corporate reorganization, each Stockholder shall vote all shares of Stock owned or held by such Stockholder in favor of the
Approved Sale and shall waive any dissenters rights, appraisal rights or similar rights in connection with such merger, consolidation or sale, or (B) a sale of all or substantially all of the capital stock of the Company, the Stockholders shall
agree to sell all shares of Stock which are the subject of the Approved Sale, on the terms and conditions of such Approved Sale. The Stockholders shall take all necessary and desirable actions in connection with the consummation of the Approved
Sale, including the execution of such agreements and such instruments and other actions reasonably necessary to (1) provide customary representations, warranties, indemnities, and escrow arrangements relating to such Approved Sale and
(2) effectuate the allocation and distribution of the aggregate consideration upon the Approved Sale as set forth in below. The Stockholders shall be permitted to sell their shares of capital stock pursuant to an Approved Sale without complying
with the provisions of the Third Amended and Restated Co-Sale and First Refusal Agreement dated as of September 30, 2002, as may be amended from time to time. 

(b) The obligations of the Stockholders pursuant to this Section 10 are subject to the satisfaction of the
following conditions: 
 (i) upon the consummation of the Approved Sale, each Stockholder shall receive the same
proportion of the aggregate consideration from such Approved Sale that such holder would have received if such aggregate consideration had been distributed by the Company in complete liquidation pursuant to the rights and preferences set forth in
the Company’s then current certificate of incorporation (giving effect to applicable liquidation preferences, if any); 
 (ii) if any Stockholders of a class are given an option as to the form and amount of consideration to be received, all Stockholders of such class will be given the same option; 

  
 10

 (iii) no Stockholder shall be obligated to make any out-of-pocket
expenditure prior to the consummation of the Approved Sale (excluding modest expenditures for postage, copies, etc.) and no Stockholder shall be obligated to pay any portion (or shall be entitled to be reimbursed by the Company for that portion
paid) that is more than its pro rata share (based upon the amount of consideration received) of reasonable expenses incurred in connection with a consummated Approved Sale, to the extent such costs are incurred for the benefit of all Stockholders,
and are not otherwise paid by the Company or the acquiring party (costs incurred by or on behalf of a Stockholder for its sole benefit will not be considered costs of the transaction hereunder), provided that a Stockholder’s liability for such
expenses shall be limited to the total purchase price received by such Stockholder for its shares of capital stock; 
 (iv) no Stockholder shall be required to provide any representations, warranties or indemnities (other than pursuant to an escrow of a percentage of consideration receivable by such Stockholder so long as
such percentage is the same for all Stockholders) in connection with the Approved Sale, other than those representations, warranties and indemnities concerning each Stockholder’s valid ownership of shares of capital stock and stock equivalents,
free of all liens and encumbrances (other than those arising under applicable securities laws), and each Stockholder’s authority, power, and right to enter into and consummate such purchase or merger agreement without violating any other
agreement to which such Stockholder is a party or its assets are bound; and 
 (v) if some or all of the
consideration received in connection with the Approved Sale is other than cash, then the valuation of such assets shall be determined in accordance with the Company’s certificate of incorporation as then currently in effect. The determination
of value shall be final and binding on all parties. 
 (c) If the Company and any of the Stockholders or their
representatives enter into any negotiation or transaction for which Rule 506 under the Securities Act of 1933, as amended (or any similar rule then in effect (the “Securities Act’)), may be available with respect to such negotiation
or transaction (including a merger, consolidation or other reorganization), each Stockholder who is not an accredited investor (as such term is defined in Rule 501 under the Securities Act), at the request of the Company, will appoint an Investor
Representative (as such term is defined in Rule 501 under the Securities Act) reasonably acceptable to the Company. 

  
 11

 4. Counterparts. This Amendment Agreement may be signed in one
or more counterparts, each of which shall be deemed an original and all of which, taken together, shall be deemed one and the same document. 
 [Signature Page Follows] 

  
 12 

 IN WITNESS WHEREOF, this Omnibus Amendment No. 1 has been executed by the
parties hereto as of the date first written above. 
  

			
	COMPANY:
	
	 NEWGISTICS, INC.,
 a Delaware Corporation

		
	By:	 	 /s/ Ray Greer

		 	      President and Chief Executive Officer

 [SIGNATURE PAGE TO OMNIBUS AMENDMENT NO. 1] 

 
			
	AUSTIN VENTURES VII, L.P.
		
	By	 	        AV Partners VII, L.P.
		 	        Its General Partner
		
	By:	 	 /s/ Kenneth P. DeAngelis

		 	         Kenneth P. DeAngelis
 General Partner

	
	AV LABS I, LP.
		
	By:	 	        AVL Partners I, L.P.
		 	        its General Partner
		
	By:	 	 /s/ Rob Adams

		 	        Rob Adams
		 	        General Partner

 [SIGNATURE PAGE TO OMNIBUS AMENDMENT NO.. 1] 

 
			
	INVESTORS AND FOUNDERS:
	
	STARVEST PARTNERS, L.P.
		
	By:	 	 StarVest Associates LLC, its

    General Partner

		
	By:	 	 /s/ Laura B. Sachar

		 	   Manager Member
	
	 STARVEST MANAGEMENT INC.,
 as nominee for

	
	 StarVest Partners, L.P. Advisory Council
 Co-Investment Plan

		
	By:	 	 /s/ Laura B. Sachar

		 	   Co-Chairman

[SIGNATURE PAGE TO OMNIBUS AMENDMENT NO. 1]

 
			
	SPIEGEL-HERMES GENERAL SERVICE LLC
		
	By:	 	  /s/ Rich Lauer

		 	  Rich Lauer

 President

 [SIGNATURE PAGE TO OMNIBUS AMENDMENT NO. 1 ] 

 
			
	USF VENTURES, INC.
		
	By:	 	 /s/ Christopher L.
Ellis

			
	Name:	 	 Christopher L.
Ellis

			
	Title:	 	 President

[SIGNATURE PAGE TO OMNIBUS AMENDMENT No. 1 ] 

 
	
	 /s/ Philip Siegel

	Philip Siegel
	
	  
 Deena
Byers

	
	  
 Steven M.
List

	
	  
 Greg A.
Moerbe

	
	  
 Kyle
Harvey

	
	  
 Casey
Leaman

	
	  
 Vinita
Busse

 [SIGNATURE PAGE TO OMNIBUS
AMENDMENT No. 1]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]